GratXray
Villigen
About GratXray
GratXray is an innovative medical device company, developing, producing and marketing systems based on phase contrast enhanced X-ray imaging. Their worldwide patented method is ideal for soft tissue imaging, as it provides unprecedented density contrast and tissue delineation in low absorbing tissues. They are focusing on applications, where classic X-ray systems fail or provide unsatisfied results. Their first focus is breast cancer imaging, which they address by developing a Grating-Interferometry Breast-Computed-Tomography (GI-BCT) system. With this true volumetric 3D approach, they will provide more precise breast tumor detection without need of contrast agents. The breast can be measured without compression, massively improving patient comfort.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Last round: Grant (May 2018)
- Website: gratxray.com
- Phone: +41 44 545 8530
Industries & Categories
Health Care, Medical, Medical Device
Social Profiles
Canonical: https://fsome.com/organization/gratxray-2688614 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.